questionsmedicales.fr
Maladies de l'appareil respiratoire
Tumeurs de l'appareil respiratoire
Tumeurs du poumon
Nodules pulmonaires multiples
Nodules pulmonaires multiples : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Nodules pulmonaires multiples : Questions médicales les plus fréquentes",
"headline": "Nodules pulmonaires multiples : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Nodules pulmonaires multiples : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-20",
"dateModified": "2025-03-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Nodules pulmonaires multiples"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs du poumon",
"url": "https://questionsmedicales.fr/mesh/D008175",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du poumon",
"code": {
"@type": "MedicalCode",
"code": "D008175",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.520"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Nodules pulmonaires multiples",
"alternateName": "Multiple Pulmonary Nodules",
"code": {
"@type": "MedicalCode",
"code": "D055613",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Y L Gao",
"url": "https://questionsmedicales.fr/author/Y%20L%20Gao",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China."
}
},
{
"@type": "Person",
"name": "R E Feng",
"url": "https://questionsmedicales.fr/author/R%20E%20Feng",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China."
}
},
{
"@type": "Person",
"name": "Kazuhiko Morikawa",
"url": "https://questionsmedicales.fr/author/Kazuhiko%20Morikawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Shigeki Misumi",
"url": "https://questionsmedicales.fr/author/Shigeki%20Misumi",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Taiki Fukuda",
"url": "https://questionsmedicales.fr/author/Taiki%20Fukuda",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012142"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du poumon",
"item": "https://questionsmedicales.fr/mesh/D008175"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nodules pulmonaires multiples",
"item": "https://questionsmedicales.fr/mesh/D055613"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Nodules pulmonaires multiples - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Nodules pulmonaires multiples",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Nodules pulmonaires multiples",
"description": "Comment sont détectés les nodules pulmonaires multiples ?\nQuels examens complémentaires sont nécessaires ?\nQuels critères évaluent la malignité des nodules ?\nLes antécédents médicaux influencent-ils le diagnostic ?\nQuelle est l'importance du suivi des nodules ?",
"url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Nodules pulmonaires multiples",
"description": "Quels sont les symptômes des nodules pulmonaires multiples ?\nLes nodules peuvent-ils causer des infections ?\nLes symptômes varient-ils selon l'étiologie ?\nPeut-on avoir des symptômes sans nodules visibles ?\nLes symptômes sont-ils toujours graves ?",
"url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Nodules pulmonaires multiples",
"description": "Comment prévenir les nodules pulmonaires ?\nLes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle le risque ?\nLe contrôle des maladies respiratoires aide-t-il ?\nLes vaccinations sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Nodules pulmonaires multiples",
"description": "Quel traitement pour les nodules bénins ?\nComment traite-t-on les nodules malins ?\nLes traitements varient-ils selon la taille des nodules ?\nY a-t-il des traitements expérimentaux ?\nLe suivi post-traitement est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Nodules pulmonaires multiples",
"description": "Quelles complications peuvent survenir ?\nLes nodules peuvent-ils causer des problèmes respiratoires ?\nY a-t-il un risque de métastases ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Nodules pulmonaires multiples",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents de cancer augmentent-ils le risque ?\nL'exposition professionnelle joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D055613?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment sont détectés les nodules pulmonaires multiples ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent détectés par radiographie ou tomodensitométrie (TDM)."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont nécessaires ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie ou une imagerie par résonance magnétique (IRM) peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Quels critères évaluent la malignité des nodules ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La taille, la forme, la calcification et l'évolution des nodules sont évaluées."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer ou de tabagisme augmentent le risque de malignité."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du suivi des nodules ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi permet de surveiller l'évolution des nodules et d'identifier des changements."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des nodules pulmonaires multiples ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent asymptomatiques, ils peuvent causer toux, douleur thoracique ou dyspnée."
}
},
{
"@type": "Question",
"name": "Les nodules peuvent-ils causer des infections ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections pulmonaires peuvent survenir en raison de l'inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'étiologie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon qu'ils sont bénins ou malins."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans nodules visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent exister sans nodules détectables par imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours graves ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, beaucoup de cas sont bénins et asymptomatiques, nécessitant juste un suivi."
}
},
{
"@type": "Question",
"name": "Comment prévenir les nodules pulmonaires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et les expositions environnementales nocives aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers sont conseillés pour les personnes à risque élevé."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut réduire le risque de cancer pulmonaire."
}
},
{
"@type": "Question",
"name": "Le contrôle des maladies respiratoires aide-t-il ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, contrôler des maladies comme l'asthme peut réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations contre la grippe et le pneumocoque peuvent prévenir des infections."
}
},
{
"@type": "Question",
"name": "Quel traitement pour les nodules bénins ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nodules bénins nécessitent souvent aucun traitement, juste une surveillance."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on les nodules malins ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nodules malins peuvent nécessiter chirurgie, chimiothérapie ou radiothérapie."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la taille des nodules ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la taille et la croissance des nodules influencent le choix du traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux comme l'immunothérapie sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Le suivi post-traitement est-il important ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le suivi est crucial pour détecter toute récidive ou complication."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'infection, l'hémorragie ou la progression vers le cancer."
}
},
{
"@type": "Question",
"name": "Les nodules peuvent-ils causer des problèmes respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nodules volumineux peuvent entraîner des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de métastases ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nodules malins peuvent se propager à d'autres organes par métastases."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares, surtout si les nodules sont surveillés correctement."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion dépend de la nature de la complication et peut nécessiter un traitement spécifique."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à des agents cancérigènes et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de nodules pulmonaires augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les antécédents de cancer augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de cancer augmente le risque de développer des nodules."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des expositions à l'amiante ou à d'autres substances toxiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...